Home/Filings/4/0000950170-25-028069
4//SEC Filing

Hassanein Waleed H 4

Accession 0000950170-25-028069

CIK 0001756262other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 6:16 PM ET

Size

21.4 KB

Accession

0000950170-25-028069

Insider Transaction Report

Form 4
Period: 2025-02-25
Hassanein Waleed H
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2025-02-25+59,781121,424 total
  • Award

    Stock Option (Right to Buy)

    2025-02-25+90,18590,185 total
    Exercise: $73.00Exp: 2035-02-25Common Stock (90,185 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    469,359
Footnotes (2)
  • [F1]Consists of 59,781 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 25, 2025 until the option is fully vested on February 25, 2029, subject to continued service.

Issuer

TransMedics Group, Inc.

CIK 0001756262

Entity typeother

Related Parties

1
  • filerCIK 0001430466

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:16 PM ET
Size
21.4 KB